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Abstract The anti-apoptotic activity of p35s from two baculo-
viruses, Autographa californica nucleopolyhedrovirus (AcNPV)
and Bombyx mori NPV (BmNPV), was compared in mammalian
cells. AcNPV p35 efficiently blocked apoptosis induced by
caspase overexpression, but BmNPV p35 did so very poorly.
Analysis of chimeric p35s and in vitro cleavage of wild type p35s
suggest that the cleavage efficiency of p35 correlates with the
blocking activity. Single amino acid substitutions of BmNPV p35
with those observed in AcNPV p35, however, resulted in
significant loss of its anti-apoptotic activity. We speculate that
sequences flanking the cleavage site have uniquely evolved during
baculovirus evolution.
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1. Introduction
The molecular mechanisms of the execution phase of the
apoptotic process are well conserved in various organisms and
recent intensive studies have identi¢ed the central component
of apoptosis, a family of cysteine proteases called caspases
(see [1^3]). Caspases have been isolated from various organ-
isms from nematodes to humans and are represented by cas-
pase-1 (interleukin-1L converting enzyme, ICE), caspase-2
(ICH-1), and caspase-3 (CPP32) [4,5].
Vertebrate and invertebrate viruses often block apoptosis
induced by viral infection in infected cells ; this process is
believed to be a defense mechanism by host cells attacked
by viruses (see [6]). Some viral proteins have been shown to
be inhibitors of mammalian caspases (see [6,7]). The caspase
inhibitors include crmA of a cowpox virus [8,9] and p35 of the
baculoviruses Autographa californica NPV (AcNPV) [10] and
Bombyx mori NPV (BmNPV) [11].
AcNPV p35 has been used extensively in the study of apop-
tosis in Caenorhabditis elegans [12], Drosophila melanogaster
[13], and mammals [14] because of its potent anti-apoptotic
activity in these organisms. In vitro studies have shown that
AcNPV p35 is a suicide substrate for caspases and that it is
cleaved at a peptide bond between Asp87 and Gly88. Cleaved
products of p35 form a stable complex with caspases, which
results in the loss of proteolytic activity, at least in vitro [15],
followed by the termination of the apoptotic process in cells.
E⁄cient inhibition of apoptosis by p35 indicates the existence
of caspase homologs in many organisms including insects. Sf
caspase-1 has recently been isolated from S. frugiperda, a
susceptible host for AcNPV replication [16]. p35 cleavage ex-
periments show that p35 is an e⁄cient substrate for Sf cas-
pase-1 in vitro [16].
There are interesting observations in terms of the pro-apop-
totic activities of baculoviruses. An AcNPV p35-deletion mu-
tant replicates very poorly and induces extensive apoptosis in
S. frugiperda cells (SF-21) [10]. Infection of B. mori cells
(BmN) with BmNPV p35-deletion mutant (BmNPV p35
shows 89.6% amino acid sequence identity to AcNPV p35
[11]) also induces the initial apoptotic response in BmN cells
such as membrane blebbing, but BmN appear to recover
afterward [11]. These observations suggest that the anti-apop-
totic activity of BmNPV p35 is not necessarily as potent as
AcNPV p35, because the apoptosis induced by BmNPV in-
fection seems to be much milder than that of AcNPV. Nucleo-
tide sequence analysis of BmNPV p35 shows that it has a
potential cleavage site for caspases at Asp87-Gly88, corre-
sponding to that of AcNPV p35. However, the BmNPV p35
protein has 28 amino acid substitutions including several ami-
no acid residues very close to the putative cleavage site.
Although the di¡erences in amino acid sequence seem to af-
fect the anti-apoptotic activity of p35, a direct comparison of
the p35 activities between these viruses has not yet been made
partly because of their di¡erent host range speci¢city [17]. We
examined BmNPV p35 for its anti-apoptotic activity in mam-
malian cells in comparison with that of AcNPV p35. Our data
show that BmNPV p35 is a less e⁄cient inhibitor of mamma-
lian apoptosis and also a poorer substrate for caspases when
compared with AcNPV p35. The evolution of p35 is also
discussed in light of the relationship between anti- and pro-
apoptotic activities of baculovirus.
2. Materials and methods
2.1. Expression plasmid
The expression constructs of the caspase family members fused with
Escherichia coli lacZ were used for the transfection of cells [18,19].
The caspase-1-lacZ and caspase-2-lacZ constructs were kindly pro-
vided by Masayuki Miura (Osaka University, Japan). All the expres-
sion constructs used in this study had the same pcDNA3 (Invitrogen,
Carlsbad, CA) vector backbone.
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Unless otherwise stated standard techniques of molecular cloning
were used as described previously [20]. The coding region of p35 of
AcNPV was ampli¢ed using Vent DNA polymerase (New England
Biolabs, Beverly, MA) and the following primers for the polymerase
chain reaction (PCR): NTOP61, 5P-CTCGGATCCATGTGTGTA-
ATTTTTCCGGTAG-3P ; NBOT52, 5P-CTCCTCGAGTTATTTAA-
TTGTGTTTAATATTACATT-3P. The ampli¢ed fragments were
digested with BamHI and XhoI and then cloned into pcDNA3 cleaved
with BamHI and XhoI to generate pNB131.
The expression construct pNB124, the BmNPV p35 cDNA in
pcDNA3, was generated by the same strategy as described above,
using NBOT53 (5P-CTCCTCGAGTTATTTAATCATGTCTAATAT-
TACATT-3P) instead of NBOT52 as a primer for PCR.
The chimeric plasmid DNAs were constructed by exchanging the
BclI-BglI (Ac-b1, Bm-a1) or BglI-AatII fragments (Ac-b2, Bm-b2)
between AcNPV and BmNPV p35.
For single residue replacements, amino acid residues Gly81, Lys85,
and Ile86, of BmNPV p35 were respectively replaced with Asp81,
Glu85, and Met86 through PCR mutagenesis with the following muta-
genic primers. Mut-81D, 5P-TTTGATCAACTAGAACGCGATTA-
CAGCGATAAAATTGATGGATTTCAC-3P ; Mut-85Q, 5P-TTTGA-
TCAACTAGAACGCGAATACAGCGATCAAATTGATGGATTT-
CAC-3P ; Mut-86M, 5P-TTTGATCAACTAGAACGCGAATACAG-
CGATAAAATGGATGGATTTCAC-3P. These primers were used
with a primer which contained AatII sequence, GACGTC: 5P-
TAAGCTACGACGTCGTACTCGTAAAGTCC-3P. PCR was done
with the BmNPV p35 gene as a template. The ampli¢ed fragments
were digested with BclI and AatII, and then exchanged with the cor-
responding BclI-AatII fragment of the coding region of BmNPV p35.
The mutagenized p35 was subcloned into pcDNA3 to generate pcBm-
mut81, pcBm-mut85, pcBm-mut86.
2.2. Cell culture and transient cotransfection
Rat-1 ¢broblast cells were maintained in culture at 37‡C with 5%
CO2 in Dulbecco’s modi¢ed Eagle’s medium containing 10% (v/v)
fetal bovine serum (BioWhittaker, Walkersville, MD) and 50 U/ml
penicillin and 50 Wg/ml streptomycin (Gibco BRL, Rockville, MD).
The day before transfection, cells were seeded at a density of 1.3U104
cells/cm2. Expression constructs were transferred to cells with lipofect-
amine reagent (Gibco BRL) according to the manufacturer’s protocol.
In total 2.0 Wg of DNA was transfected in a 35 mm diameter culture
dish: 0.5 Wg of lacZ fusion constructs (either casp-1-lacZ, casp-2-lacZ
or control lacZ) and 1.5 Wg of the test plasmid (either p35, CD20 or
pcDNA3). The expression of chimeric genes in cells was detected by
staining with 5-bromo-4-chloro-3-indolyl L-D-galactopyranoside (X-
gal) [18,19].
2.3. In vitro cleavage
For in vitro synthesis of p35 proteins, the p35 genes were recloned
into pBluescript II SK(3) vector after ampli¢cation of the p35 coding
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Fig. 1. A: Cotransfection assay for suppressor activity of BmNPV and AcNPV p35. Rat-1 cells were transiently transfected with the expression
constructs, ¢xed 24 h later, and stained with X-gal solution for 3 h. The data shown are the percentage of round blue cells among the total
number of blue cells counted. In each transfection, over 200 blue cells were randomly chosen and counted. The data were collected from three
independent experiments. Either lacZ (hatched bars), casp-1-lacZ (black bars) or casp-2-lacZ (gray bars) were transfected with either CD20 (N),
AcNPV p35 (A), BmNPV p35 (B), Bm-a1 (1), Ac-b2 (2), Ac-b1 (3), or Bm-a2 (4). B: Comparison of BmNPV p35 and AcNPV p35. Amino
acid sequences covering region 1 and region 2 are compared between AcNPV p35 and BmNPV p35. Conserved amino acid residues are indi-
cated with colons (:), sequence di¡erences are marked with dots (.). The cleavage site of AcNPV p35 by caspase-1 is indicated by an arrow.
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region. The conditions of the PCR were as described above, except
that the upstream primer, 5P-TCGGATCCGCCACCATGTGTG-
TAATTTTTCCGGTA-3P, contained a consensus Kozak sequence,
GCCACCATG. 35S-Labeled proteins were prepared by in vitro tran-
scription and translation using the T7-coupled TNT reticulocyte lysate
system (Promega, Madison, WI) and [35S]methionine (Amersham,
Buckinghamshire, UK). Labeled proteins were incubated at 30‡C
with E. coli lysates containing either caspase-1 or caspase-2 [21].
The reaction mixture contained 25 mM HEPES (pH 7.5) with 5 mM
EDTA, 5 mM dithiothreitol, 10% sucrose, 10 Wg/ml leupeptin and
250 WM phenylmethylsulfonyl £uoride. Amounts of proteins used
for cleavage reactions were 0.5 Wl of the labeled protein and 23^
28 Wg of proteins in bacterial lysates. Cleavage products were analyzed
by 15% SDS-polyacrylamide gel electrophoresis. Detection of proteins
was done by autoradiography with a BAS2000 Bioimaging analyzer
(Fuji Film, Japan).
3. Results
3.1. Anti-apoptotic activity of BmNPV p35
To analyze the anti-apoptotic activity of BmNPV p35 in
comparison with AcNPV p35, a transient expression system
was used to overexpress p35 and caspase in mammalian cells.
Either AcNPV p35 or BmNPV p35 with either caspase-1
(ICE) [18] or caspase-2 (ICH-1) [19] was examined, since
transfection assay and in vitro proteolysis analysis suggest
that caspase-1 and caspase-2 have di¡erent speci¢cities for
substrates [19,22], although both enzymes can cleave AcNPV
p35 in vitro [15]. Expression constructs of casp-1 and casp-2
fused with E. coli lacZ have been successfully used to demon-
strate that their overexpression induces apoptosis in mamma-
lian cells [18,19]. Transfected cells can easily be detected by
staining with X-Gal due to the L-galactosidase activity of the
lacZ gene product. Dead cells are identi¢ed by their round
shape and small size as compared to healthy cells, which are
£at and well-attached to the culture plate (data not shown)
[18].
Fig. 1A shows that the overexpression of either casp-1 or
casp-2 induces apoptosis of Rat-1 ¢broblast cells when they
are introduced into cells with a negative control, CD20 cell
surface marker [23]. Dead cells stained with anti-L-galactosi-
dase antibody and Hoechst 33258 had fragmented nuclei, one
of the hallmarks of cells undergoing apoptosis (data not
shown). The background level of cell death induced by
transfection with lacZ (control) was around 25%. The percen-
tages of cell death induced by the caspases are over 90%
of transfected cells (X-gal positive cells). With the cotrans-
fection of the caspases and AcNPV p35, the cell-killing activ-
ities of both caspase-1 and caspase-2 were e⁄ciently sup-
pressed and the percentage of dead cells decreased to 45%
(for caspase-1) and 30% (for caspase-2). These results were
consistent with the in vitro data which have shown that the
AcNPV p35 is an e⁄cient suicide substrate for both caspases
[15].
With the overexpression of BmNPV p35, however, the per-
centages of dead cells after cotransfection with the caspases
were around 90% for caspase-1 and 65% for caspase-2. The
percentages of cell killing in the presence of BmNPV p35 were
reproducibly higher than those with AcNPV p35 (30^45%),
although the percentage was lower than those of CD20 con-
trols (nearly 100% for caspase-1 and 90% for caspase-2).
Although caspase-2-induced apoptosis was signi¢cantly inhib-
ited by BmNPV p35, these results indicate that BmNPV p35
can suppress the cell killing activity of the caspases at a lower
e⁄ciency than AcNPV p35.
3.2. Location of the region which a¡ects the anti-apoptotic
activity of p35
BmNPV p35 and AcNPV p35 are both 299 amino acid long
polypeptides and possess 28 amino acid substitutions between
them [11]. Among these substitutions, there are two highly
variable regions, region 1 and region 2 (see Fig. 1B). Region
1, from the 81st residue through the 94th residue, possessed
¢ve amino acid substitutions (35% mismatch). This region of
AcNPV p35 contains the cleavage site (Asp87-Gly88) for the
caspases [15,24]. Region 2 (between the 132nd residue and the
148th residue) contained ¢ve amino acid substitutions (29%
mismatch) (see [11]). Taking advantage of identical restriction
enzyme sites £anking the region 1 DNA fragments, we made
chimeric constructs: a BmNPV p35-based chimera whose
Leu78 through Lys97 was replaced with its counterpart of
AcNPV p35 (Bm-a1) and, vice versa, an AcNPV p35-based
chimera which had the probable cleavage site of BmNPV (Ac-
b1). These chimeric constructs were used for cotransfection
experiments in mammalian cells to examine whether or not
region 1 was involved in the di¡erence in the anti-apoptotic
activities of BmNPV and AcNPV p35s observed in the tran-
sient assay. In addition, region 2 was switched between
AcNPV and BmNPV p35 proteins, generating two more chi-
meras (Ac-b2 and Bm-a2).
Fig. 1A shows the comparison of anti-apoptotic activities of
the chimeric constructs with that of AcNPV p35 or BmNPV
p35. p35 chimeras Bm-a1 and Ac-b2, both of which contained
region 1 of AcNPV p35, showed suppressor activities similar
to those observed in the transfection of the original AcNPV
p35 (about 60% cell death in the case of caspase-1, and 30^
45% cell death for caspase-2). However, p35 chimeras Ac-b1
and Bm-a2, both of which contained region 1 of BmNPV p35,
showed suppressor activities as weak as the original BmNPV
p35 (over 80% cell death for caspase-1, over 60% cell death
for caspase-2). Sequences £anking the cleavage site (Asp87-
Gly88) thus appear to be a principal determinant of the sup-
pressor activity of p35s. These results indicated that (1)
BmNPV p35 possessed signi¢cantly lower anti-apoptotic ac-
tivity against caspases compared to AcNPV p35 and (2) the
di¡erence in anti-apoptotic activity was due to the amino acid
substitutions surrounding the cleavage site of caspases located
in region 1.
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Fig. 2. In vitro cleavage of p35s by caspase-1 and caspase-2.
[35S]Methionine-labeled p35 was incubated with an E. coli lysate
containing either caspase-1 or caspase-2 for 10 or 60 min at 30‡C.
Arrowheads indicate intact p35 protein and its cleaved products of
25 kDa and 10 kDa. Note that the in vitro translated p35 sample
contains a smaller protein of about 30 kDa, which is presumably
generated by non-speci¢c transcription.
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3.3. In vitro cleavage of p35s
Xue and Horvitz [15] suggest the possibility that AcNPV
p35 could inhibit caspases by its prolonged association with
caspases as a poor substrate (by being cleaved ine⁄ciently).
To examine the e⁄ciency of cleavage of AcNPV and BmNPV
p35s by caspases in vitro, p35 polypeptides were labeled by in
vitro translation using reticulocyte lysates and
[35S]methionine. Fig. 2 shows that p35 proteins of both
AcNPV and BmNPV were cleaved by bacterial lysates con-
taining either caspase-1 or caspase-2. The sizes of the proteo-
lytic fragments are approximately 25 kDa (p25) and 10 kDa
(p10), suggesting that both caspases cleave the p35 proteins at
the same site in region 1. In addition to p35, there was an-
other protein of about 30 kDa, which may have been a non-
speci¢c product, since the band intensity of the 30 kDa pro-
tein remained unchanged following the cleavage reaction (Fig.
2).
Quantitative analysis of the cleaved products showed that
32% of AcNPV p35 was cleaved by caspase-1 after incubation
for 60 min, while only 12% of BmNPV p35 was cleaved under
the same conditions. Caspase-2 cleaved 87% of AcNPV p35
and 61% of BmNPV p35 proteins during a 60 min incubation.
Since anti-apoptotic activity of the AcNPV p35 was stronger
than that of BmNPV p35 for both caspases, the results of the
in vitro cleavage assay suggest that the more e⁄ciently cleaved
caspase substrate has a stronger anti-apoptotic activity.
3.4. Anti-apoptotic activity of arti¢cially mutated p35s
To examine if a particular amino acid substitution between
the two p35 proteins is mainly responsible for the di¡erence in
the anti-apoptotic activity, we introduced a series of muta-
tions into BmNPV p35 so that each mutant sequence was
more similar to the amino acid sequence of AcNPV p35
than the wild type BmNPV p35. Since four amino acid resi-
dues around the cleavage site (P4 through P1) and a following
P1P residue in substrates determine the cleavage e⁄ciency by
caspases [22,25], we focused on the sequence di¡erences at P3
and P2 positions between BmNPV p35 and AcNPV p35 (see
Fig. 1B). Mutant versions of BmNPV p35s, Mut85(K/Q) and
Mut86(I/M), as well as a control mutant protein, Mut81(E/
D), were subjected to the cotransfection assay with caspases as
described above. We expected that Mut85(K/Q) and/or
Mut86(I/M) would show higher anti-apoptotic activity than
BmNPV p35 of wild type. All the mutant proteins (Mut81,
Mut85, Mut86), however, were less e¡ective in suppressing
apoptosis induced by either caspase-1 or caspase-2, although
expression of these mutant proteins made cells a little more
resistant to caspases than cells transfected with a vector con-
trol (Fig. 3). We could not therefore attribute the di¡erence in
anti-apoptotic activity to a single amino acid substitution be-
tween these p35 proteins. This result suggests the possibility
that the amino acid sequences, especially within the region 1,
of either BmNPV p35 or AcNPV p35 is not tolerant to muta-
tion, which would result in great decrease of its anti-apoptotic
activity (see Section 4).
4. Discussion
p35 is found in two baculoviruses, BmNPV and AcNPV,
which share high (90^95%) nucleotide sequence homology be-
tween their genomes [11]. Extensive functional analysis has
only been done using AcNPV p35, which e⁄ciently blocks
caspases from various organisms. In this study, we compared
BmNPV and AcNPV p35 in the same cell line with two di¡er-
ent caspases. Both p35s had anti-apoptotic activities against
both caspase-1 and caspase-2, suggesting that BmNPV p35 as
well as AcNPV p35 can block di¡erent subspecies of caspases.
We showed that BmNPV p35 is weaker than AcNPV p35 in
terms of the suppression of either caspase-1- or caspase-2-
induced apoptosis in mammalian cells. We also observed sim-
ilar results for the di¡erent activities of the suppression of
apoptosis using mouse myoblast cells, C2C12 (data not
shown). Therefore, our system using mammalian cell lines
appear to be useful for insect apoptosis studies involving cas-
pases.
The in vitro cleavage study of p35 showed that AcNPV p35
appeared to be more e⁄ciently cleaved by either caspase-1 or
caspase-2 than BmNPV p35. This result suggests that the
cleavage e⁄ciency of p35 correlated with its anti-apoptotic
activity, i.e. the better substrate for caspases is a more e⁄cient
inhibitor of apoptosis (by blocking caspase activities more
e⁄ciently). It has been found that AcNPV p35 is cleaved
into two fragments, p25 and p10, by caspases and that the
cleaved product(s) subsequently form a stable complex with
caspases, resulting in the loss of activity of the caspases [15].
In addition to the cleavage e⁄ciency, the stability of the p35-
protease complex could also a¡ect the inhibitory activity of
p35 over caspases. It is possible that the stability of complexes
formed between cleaved AcNPV p35 and the proteases is dif-
ferent from those formed with BmNPV p35, as these p35
proteins have 28 amino acid residue di¡erences from each
other.
Biochemical studies regarding the substrate speci¢city of
caspases have shown that caspases can cleave oligopeptides
with di¡erent sequences, although it de¢nitely requires an
Asp residue at the P1 position [5,22,25]. Four amino acid
residues including the cleavage site Asp residue (P4 through
P1 position) and a following P1P residue determine the cleav-
age e⁄ciency [22,25]. Among these residues, the P4 residue is
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Fig. 3. Cotransfection assay for suppressor activity of mutated
BmNPV p35. Rat-1 cells were transiently cotransfected with cas-
pase-1 or caspase-2 and the mutant versions of BmNPV p35
(Mut81, Mut85, Mut86), and cell death was assayed as described in
Fig. 1A. Bars represent the percentages of dead cells. pcDNA3 vec-
tor was used for the control plasmid. lacZ (hatched bars), casp-1-
lacZ (black bars), casp-2-lacZ (gray bars).
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the key determinant of the distinct substrate preferences of the
various caspase homologs [22,25]. The P2 and P3 residues
have been thought to be less important for the substrate spe-
ci¢city, since X-ray crystallographic analyses of caspases have
shown that there are less extensive contacts of caspases with
P2 and P3 amino acids [26^28]. The sequence of P4 through
P1P in AcNPV p35 is DQMD87G88 while the corresponding
sequence in BmNPV p35 is DKID87G88. It is interesting to
note that the di¡erences at these P2 (Met in AcNPV p35, Ile
in BmNPV p35) and P3 (Gln and Lys) positions appear to be
the major determinant for the di¡erence in their anti-apop-
totic activities which balance the apoptosis-inducing activities
of respective viruses.
Our cotransfection assay has revealed that a single amino
acid mutation introduced into BmNPV p35 in an arti¢cial
manner results in signi¢cant decrease of the anti-apoptotic
activity. The mutant versions of p35s all have a common
sequence of DxxD87G88 at the cleavage site for caspases. In
vitro cleavage studies of these mutant proteins showed that
they were cleaved by caspases not less e⁄ciently than BmNPV
p35 of wild type (data not shown). It is likely that such a low
suppressor activity is not due to their cleavage e⁄ciencies, but
to either instability of the mutant proteins themselves in cells
or reduced stability of pre- or postcleavage association of
them with caspases. As for AcNPV p35, site-directed muta-
genesis of the protein has revealed that p35 stability is unusu-
ally sensitive to mutagenesis, as most of p35 mutant proteins
showed much decreased level of accumulation in insect cells
[29].
Induction of apoptosis during baculovirus replication sug-
gests an important role of the induction of apoptosis for suc-
cessful replication of baculoviruses in insect cells. Baculovi-
ruses can e⁄ciently replicate in cells during the initial stages
of apoptosis in which normal functions of host cells are ab-
rogated [11]. In cells with normal metabolism, synthesis of
viral DNAs and proteins should compete with those of host
cells. If an NPV has a weak activity for induction of apopto-
sis, the anti-apoptotic proteins encoded by the NPV would be
moderate accordingly. Although factors of apoptosis induced
by NPVs are not well characterized, we presume that apop-
tosis in B. mori cells induced by BmNPV infection is weaker
than that induced by AcNPV in S. frugiperda (see Section 1).
The di¡erent anti-apoptotic activity observed between
BmNPV p35 and AcNPV p35 is thus consistent with the
idea that the anti-apoptotic activity of p35 is well balanced
with the apoptosis-inducing activity of NPV.
AcNPV has the widest host range among baculoviruses
(more than 30 host species) while BmNPV has a very narrow
(one species) host range. Phylogenetic studies of insects and
viruses have suggested that BmNPV has evolved in last 1000
years from its ancestors including AcNPV. Amino acid sub-
stitutions found in BmNPV p35 may be an important evolu-
tionary process for adaptation to a host so that the virus can
express an appropriate level of anti-apoptotic activity. A sin-
gle amino acid substitution in the AcNPV p35 protein which
could have occurred during evolution would result in loss
of suppressor function as discussed above. It is more likely
that only a set of mutations can modulate the p35 activity
without severe decrease of the suppressor activity. This may
explain why BmNPV p35 has acquired 28 amino acid substi-
tutions for only 1000 years of its evolution. We have exam-
ined the suppressor activity of p35 in mammalian cells. In
order to study the function of p35 during baculoviral replica-
tion in cell lines and insect larvae, we are currently construct-
ing AcNPV and BmNPV mutants possessing chimeric p35s
which will be used to determine the importance of regions 1
and 2.
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